Senate Special Committee on Aging Seeks Briefing From Mylan (MYL) Over Epipen Pricing

August 24, 2016 1:14 PM EDT

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

(Updated - August 24, 2016 1:18 PM EDT)

The U.S. Senate Special Committee on Aging seeks to brief Mylan (Nasdaq: MYL) over Epipen pricing. PDF file is below.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Hot Corp. News, Litigation, Trader Talk

Add Your Comment